Literature DB >> 11067931

Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype.

M K Maini1, N Gudgeon, L R Wedderburn, A B Rickinson, P C Beverley.   

Abstract

We have applied a sensitive global analysis of TCR heterogeneity to compare clonal dynamics of CD4(+) and CD8(+) T cells in acute infectious mononucleosis. Using this approach, we are able to identify a broad representation of the total virus-specific population without the bias of in vitro culture and then to track their phenotype and fate by their unique molecular footprint. We demonstrate a large number of Ag-driven clones using different TCRs in the acute phase, all CD8(+). The diverse large clones generated in the CD8 subset in response to this virus contrast with the complete lack of detectable clonal expansion in the CD4 compartment. Many of the same clones remain detectable in directly ex vivo CD8(+) T cells for at least a year after resolution of infectious mononucleosis, although the clone size is reduced. Thus, memory CD8 cells following EBV infection persist at relatively high circulating frequency and represent a subset of the large range of clonotypes comprising the acute effectors. Separation of samples into CD45RA (naive) and CD45RO (memory) fractions shows the accumulation of identical CDR3 region defined clonotypes in both CD45RO and CD45RA fractions and sequencing confirms that dominant long-lived monoclonal expansions can reside in the CD45RA pool.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067931     DOI: 10.4049/jimmunol.165.10.5729

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  23 in total

1.  Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus.

Authors:  Martina Sester; Urban Sester; Barbara Gärtner; Boris Kubuschok; Matthias Girndt; Andreas Meyerhans; Hans Köhler
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

2.  Lymphoid tissues from patients with infectious mononucleosis lack monoclonal B and T cells.

Authors:  Julie A Plumbley; Hongxin Fan; Phyllis A Eagan; Aamir Ehsan; Bertram Schnitzer; Margaret L Gulley
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

3.  Mouse model for acute Epstein-Barr virus infection.

Authors:  Tristan Wirtz; Timm Weber; Sven Kracker; Thomas Sommermann; Klaus Rajewsky; Tomoharu Yasuda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-16       Impact factor: 11.205

4.  T-cell clones of uncertain significance are highly prevalent and show close resemblance to T-cell large granular lymphocytic leukemia. Implications for laboratory diagnostics.

Authors:  Min Shi; Horatiu Olteanu; Dragan Jevremovic; Rong He; David Viswanatha; Heidi Corley; Pedro Horna
Journal:  Mod Pathol       Date:  2020-05-13       Impact factor: 7.842

5.  The developing human immune system: T-cell receptor repertoire of children and young adults shows a wide discrepancy in the frequency of persistent oligoclonal T-cell expansions.

Authors:  L R Wedderburn; A Patel; H Varsani; P Woo
Journal:  Immunology       Date:  2001-03       Impact factor: 7.397

Review 6.  The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.

Authors:  Olivia M Martinez; Sheri M Krams
Journal:  Transplantation       Date:  2017-09       Impact factor: 4.939

7.  Inducible nitric oxide synthase in T cells regulates T cell death and immune memory.

Authors:  Monika Vig; Smita Srivastava; Usha Kandpal; Hadassah Sade; Virginia Lewis; Apurva Sarin; Anna George; Vineeta Bal; Jeannine M Durdik; Satyajit Rath
Journal:  J Clin Invest       Date:  2004-06       Impact factor: 14.808

8.  In vivo T lymphocyte dynamics in humans and the impact of human T-lymphotropic virus 1 infection.

Authors:  Becca Asquith; Yan Zhang; Angelina J Mosley; Catherine M de Lara; Diana L Wallace; Andrew Worth; Lambrini Kaftantzi; Kiran Meekings; George E Griffin; Yuetsu Tanaka; David F Tough; Peter C Beverley; Graham P Taylor; Derek C Macallan; Charles R M Bangham
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

9.  How does HTLV-I persist despite a strong cell-mediated immune response?

Authors:  Becca Asquith; Charles R M Bangham
Journal:  Trends Immunol       Date:  2007-11-26       Impact factor: 16.687

10.  Phenotypic differences between healthy effector CTL and leukemic LGL cells support the notion of antigen-triggered clonal transformation in T-LGL leukemia.

Authors:  Marcin W Wlodarski; Zachary Nearman; Anna Jankowska; Nina Babel; Jennifer Powers; Patrick Leahy; Hans-Dieter Volk; Jaroslaw P Maciejewski
Journal:  J Leukoc Biol       Date:  2007-12-17       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.